Amy Wesa

First Name*

Last Name*

Email*

Phone*

Message*

I am authorized to claim this profile. I agree Eventually may contact me regarding my request.

Your request has been received.
Thank you.

Oops! Something went wrong while submitting the form.

First Name*

Last Name*

Email*

Phone*

Message*

Amy Wesa and Eventually may contact me regarding my request.

Your request has been received.
Thank you.

Oops! Something went wrong while submitting the form.

Contact Amy

Amy Wesa

SVP Preclinical and Translational Research

Vita Therapeutics

20 years experience in translational tumor immunology, primarily in cell & gene therapy for oncology: CART, iPSC, NK, DC, APCs. Led R&D strategy for clinical translation: from product development, to proof-of-concept studies, biomarker development, to preclinical safety, to Phase I clinical trial. Prepared and contributed to regulatory filings (DMF, IND, IB). Managed scientific staff, PhD scientists and contract service organizations. Led preclinical model development in vitro and in vivo, including humanized mouse models. Fostered external collaborations with key thought leaders in industry and academia with diverse clinical and translational research interests (inflammation, regenerative medicine, and immunotherapy) for applications in a range of medical conditions.

Talks About
#immunology #stemcells

Preferred Locations
#NorthAmerica

Speaking Engagements

3rd Annual iPSC Derived-Cell Therapies Summit

Paid

The 3rd Annual iPSC Derived-Cell Therapies Summit invites all those interested in the iPSC space to join and share their knowledge and experience in discovery, translation, and clinical strategy. This event aims to unite peers to identify current bottlenecks and showcase the pre-clinical and clinical landscape. Attendees will have the opportunity t

03-04 October 2023

Healthcare

Claim Your Profile Request

Speaker Contact Request

SPEAKER

Amy Wesa

SVP Preclinical and Translational Research

Speaking Engagements

3rd Annual iPSC Derived-Cell Therapies Summit